ArticleProceedings (Baylor University. Medical Center)2024

Cabozantinib as an emerging standard of care in renal cell carcinoma: clarifying the data?

Maria I JuarezPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.